Key result
I(Ks) blockade with chromanol 293B or HMR 1556 had neutral arrhythmogenic effects during simulated ischemia and reperfusion in guinea-pig ventricular tissue.
Why the study?
Does I(Ks) blockade alter action potential duration and prevent arrhythmias in an in vitro model of guinea-pig ventricular myocardium during simulated ischemia and reperfusion?
Does I(Ks) blockade alter action potential duration and prevent arrhythmias in an in vitro model of guinea-pig ventricular myocardium during simulated ischemia and reperfusion?
I(Ks) blockade does not prevent ventricular arrhythmias during simulated ischemia and reperfusion in a guinea-pig ventricular myocardium model.
Neutral effects in guinea-pig ischemia model caution against antiarrhythmic assumptions; leaves open translational human studies.
I(Ks) blockade might be a promising way to treat tachyarrhythmia because of the accumulation of activated potassium channels. However, I(Ks) blockade during ischemia/reperfusion has not been investigated. Thus, the electrophysiological effects of two I(Ks) blockers, chromanol 293B (10 μm) and HMR 1556 (1 μm), were assessed in an in vitro model of border zone between normal and ischemic/reperfused right ventricular myocardium from guinea-pigs, and classic electrophysiological parameters and the incidence of arrhythmias were studied. HMR 1556 and chromanol 293B exhibited slight conventional class III effects on action potential duration in the normal zone (NZ) (APD(90) : -2 ± 5%, not significant (NS); +6 ± 3%, NS; and +5 ± 1%, P < 0.05, respectively, in control, HMR 1556, and chromanol 293B groups) but failed to oppose its decrease after 30 min of simulated ischemic superfusion (APD(90) : -52 ± 5%, P < 0.01; -64 ± 5%, P < 0.01; and -61 ± 3%, P < 0.01, respectively, in control, HMR 1556, and chromanol 293B groups), leading to repolarization dispersion between normal and ischemic zones. Chromanol 293B and HMR 1556 prolonged APD(90) during reperfusion, respectively, by +11 ± 1%, P < 0.01 and +25 ± 4%, P < 0.01 in the NZ and by +13 ± 3%, NS and +31 ± 2%, P < 0.01 in the simulated ischemic zone. Both compounds exhibited neutral arrhythmogenic effects during ischemia or reperfusion. Thus, I(Ks) blockade was neutral on the occurrence of ventricular arrhythmias during ischemia and reperfusion in guinea-pig ventricular tissue.
No takes yet. Share an insight, caveat, or question.
Puddu et al. (2011) studied Ischemia/reperfusion arrhythmias. I(Ks) blockers (chromanol 293B and HMR 1556) vs. Control was evaluated on Electrophysiological parameters (APD90) and incidence of arrhythmias. I(Ks) blockade with chromanol 293B or HMR 1556 had neutral arrhythmogenic effects during simulated ischemia and reperfusion in guinea-pig ventricular tissue.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: